Impact of Major Depression and Antidepressant Use on Alcoholic and Non-Alcoholic Fatty Liver Disease: A Population-based Study

Oct-21

Hepatology Mental Health Pharmacoepidemiology

AUTHORS : Dr Abdel Aziz Shaheen, Department of Medicine and Community Health Sciences, Division of Gastroenterology and Hepatology, O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 6D25, Calgary, Alberta T2N 4Z6, Canada – Email: aashahee@ucalgary.ca – Profile: http://www.ucalgary.ca/communityhealthsciences_info/profiles/1-7523637

JOURNAL : Liver International

REFERENCE: 41(10):2308-2317

DOI : 10.1111/liv.14973

Impact of Major Depression and Antidepressant Use on Alcoholic and Non-Alcoholic Fatty Liver Disease: A Population-based Study

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer’s, Parkinson’s and dementia at age 65: a study using medical records from France and the UK General Practitioners